PDB14 COST-EFFECTIVENESS ANALYSIS OF THE ACARBOSE PHARMACOLOGICAL TREATMENT AS A PREVENTIVE MEASURE OF THE DEVELOPMENT OF TYPE 2 DIABETES IN SUBJECTS DIAGNOSED OF IMPAIRED GLUCOSE TOLERANCE (IGT)
Nov 1, 2003, 00:00
10.1016/S1098-3015(10)61738-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)61738-X/fulltext
Title :
PDB14 COST-EFFECTIVENESS ANALYSIS OF THE ACARBOSE PHARMACOLOGICAL TREATMENT AS A PREVENTIVE MEASURE OF THE DEVELOPMENT OF TYPE 2 DIABETES IN SUBJECTS DIAGNOSED OF IMPAIRED GLUCOSE TOLERANCE (IGT)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61738-X&doi=10.1016/S1098-3015(10)61738-X
First page :
Section Title :
Open access? :
No
Section Order :
185